Status:
RECRUITING
Bariatric Surgery and Pharmacokinetics of Irbesartan
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
St. Olavs Hospital
Volvat Medisinsk Senter Stokkan
Conditions:
Obesity, Morbid
Eligibility:
All Genders
18-70 years
Brief Summary
Changes to gastric pH, gastric emptying time, gastrointestinal transit-time or the pre-systemic metabolizing effect of enzymes secreted in the mucosa may all alter the pharmacokinetics of medicines. T...
Eligibility Criteria
Inclusion
- Preparing to undergo gastric bypass or sleeve gastrectomy in Central Norway
- Being a Norwegian citizen
Exclusion
- Having previously undergone resections in the GI-tract
Key Trial Info
Start Date :
November 2 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03476603
Start Date
November 2 2016
End Date
October 1 2026
Last Update
June 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Olavs University Hospital
Trondheim, Norway